H1N1 and the use of multi-dose vials in mass vaccination
Gardner, Anne (2009) H1N1 and the use of multi-dose vials in mass vaccination. Australian Nursing Journal, 17 (4). p. 13.
|PDF (Published Version) - Repository staff only - Requires a PDF viewer such as GSview, Xpdf or Adobe Acrobat Reader|
View at Publisher Website: http://www.anf.org.au/html/publications_...
The World Health Organization policy statement on multi-dose vials states quite clearly that "the risk of contamination is higher in a multidose vial than in a single-dose vial because the vaccine is repeatedly exposed - every time a dose is withdrawn" (WHO 2000). In Australia, the 2004 Communicable Diseases Network Australia (CDNA) guidelines, approved by the Department of Health and Ageing state that "The Australian Drug Evaluation Committee advised that injectable products packaged in multi-dose vials should not be used, except where products such as insulin are intended solely for the exclusive use of an individual patient".
|Item Type:||Article (Short Note)|
This article does not have an abstract.
|FoR Codes:||11 MEDICAL AND HEALTH SCIENCES > 1110 Nursing > 111002 Clinical Nursing: Primary (Preventative) @ 100%|
|SEO Codes:||92 HEALTH > 9204 Public Health (excl. Specific Population Health) > 920407 Health Protection and/or Disaster Response @ 100%|
|Deposited On:||17 May 2010 09:20|
|Last Modified:||12 Feb 2011 03:46|
Last 12 Months: 0
Repository Staff Only: item control page